Pharma Marketing Network Home

Pharma Marketing Glossary TM reflects the experience and knowledge of contributors who are experts in the field of pharmaceutical marketing. Included along with formal definitions are unique insights and quotes from these experts and other sources.

Google


This Site
Web


We accept advertising relevant to the interests of our members.
For more information, see:

Media Kit





Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing Network
Pharma Marketing News e-Newsletter | Subscribe | Pharma Marketing Online DIscussion Forum
Pharma Marketing Glossary | Pharma Marketing Resources | Case Studies | Surveys
Vendor Directory | Pharma Marketing Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

The Pharma Marketing Glossary
Reminder Ad

Similar or Alternative Terms Meaning the Same Thing Reminder Advertisement, Reminder Labeling, Reminder DTC Ad
Related Term(s) Help-Seeking Ad, disease awareness ad, book ending

Definition

A reminder ad mentions the pharmaceutical brand name but not the indication or medical condition it treats.

An example would be the Viagra TV "Joe" ads where everyone notices something different about Joe but can't quite pin down what it is ("You got a raise?").

Reminder ads, like help-seeking ads, do not require any disclosure information.

Source: "FDA Draft Guidance for Print DTCA: Less than Feared," Pharma Marketing News, Vol. 3, #2; REPRINT #32-03.


Reminder advertisements are identified as an exemption to the advertisement regulations, including provisions to provide a brief summary. Reminder advertisements " . . . call attention to the name of the drug product but do not include indications or dosage recommendations for use of the drug product. . . . and, optionally, information . . . containing no representation or suggestion relating to the advertised drug product." Reminder advertisements cannot make a representation about the product or suggest a use for the product.

Source: FDA, Division of Drug Marketing, Advertising and Communications, Frequently Asked Questions (FAQs)Reminder Advertisements and Labeling.


Reminder labeling is exempt from the requirements for adequate directions for use and adequate warnings. Reminder labeling, as defined in 21 CFR 201.100(f), is exempted. Reminder labeling calls attention to the name of the drug product but does not include indications or dosage recommendations for use. Reminder labeling may contain only the proprietary name of the drug, the established name of each active ingredient, and optionally, information relating to quantitative ingredient statements, dosage form, quantity of package contents, price, and other limited information.

The exemption does not apply to products with black box warnings in their approved product labeling. Source: FDA, Advertising/Labeling Definitions


Return to Pharma Marketing Glossary Index Page to select another term or click on a letter below to view a list of terms beginning with that letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Submit a Definition to The Pharma Marketing Glossary

If you would like to submit an alternative definition of this term or one for a new term, or if you have more information that relates to this term, including opinions, illustrations of how the term is used or misused, etc., please submit your contribution using The Pharma Marketing Glossary Entry Form. Thank you.


Pharma Marketing News e-Newsletter | Subscribe | Pharma Marketing Online DIscussion Forum
Pharma Marketing Glossary | Pharma Marketing Resources | Case Studies | Surveys
Vendor Directory | Pharma Marketing Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

© 2004 VirSci Corporation. All rights reserved.